Janney Montgomery Scott Upgrades Sarepta Therapeutic (SRPT) to Buy
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $18.00 +5.76%
Rating Summary:
18 Buy, 19 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 19
Rating Summary:
18 Buy, 19 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 19 | New: 19
Join SI Premium – FREE
Janney Montgomery Scott upgraded Sarepta Therapeutic (NASDAQ: SRPT) from Neutral to Buy with a price target of $65.00.
For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.
Shares of Sarepta Therapeutic closed at $28.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Reiterates Outperform Rating on Sarepta Therapeutics (SRPT)
- Rosenblatt Upgrades Comcast Corp (CMCSA) to Buy, 'Spin Fires Up Media Value'
- Citi Upgrades Texas Capital Bancshares (TCBI) to Neutral
Create E-mail Alert Related Categories
UpgradesRelated Entities
Janney Montgomery ScottSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
